BGI-Hong Kong 3730 Production Center begins operating, providing fast Sanger-type sequencing services

The subsidiary of BGI headquarters in Shenzhen has over 100 genome sequencers and a cloud computing platform. It is dedicated to the genetic service-related industries such as prenatal diagnosis, personal genetic risk assessment, the pharmaceutical industry, anti-cancer drug screening, and personal health spectrum checks.

BGI press release, Occtober 28, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny